日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trial

三氟尿苷-替吡嘧啶治疗既往接受过治疗的雌激素受体阳性、HER2阴性转移性乳腺癌患者(BOOG 2019-01 TIBET试验):一项单臂、多中心、II期试验

Guchelaar, Niels A D; Mathijssen, Ron H J; de Boer, Maaike; van Bekkum, Marlies L; Heijns, Joan B; Vriens, Birgit E P J; van Rosmalen, Mandy M; Kessels, Lonneke W; Hamming, Lisanne; Beelen, Karin J; Nieboer, Peter; van den Berg, Susan M; Hoop, Esther Oomen-de; Bijlsma, Rhodé M; Bos, Monique E M M

Complete responders in patients with HER2-positive metastatic breast cancer: a real-world SONABRE study

HER2阳性转移性乳腺癌患者的完全缓解:一项真实世界的SONABRE研究

Ding, Nan; Visserman, Renee; Geurts, Sandra M E; Tol, Jolien; Vriens, Birgit E P J; Aaldering, Kirsten N A; Boon, Eline; Dercksen, Marcus W; van den Berkmortel, Franchette; Pepels, Manon J A E; Peters, Natascha A J B; Heijns, Joan B; van de Winkel, Linda; de Fallois, Aude J O; Tjan-Heijnen, Vivianne C G; de Boer, Maaike

Adding Anti-HER2 Therapy to Neoadjuvant Endocrine Therapy Seems Effective in Hormone Receptor and HER2 Positive Breast Cancer Patients Unfit for Chemotherapy: A Nationwide Population-Based Cohort Study

一项全国性人群队列研究表明,对于不适合化疗的激素受体阳性且HER2阳性的乳腺癌患者,在新辅助内分泌治疗中加入抗HER2疗法似乎有效。

de Bruijn, Anne; Schipper, Robert-Jan; Voogd, Adri C; Pullens, Marleen J J; Bloemen, Johanne G; de Munck, Linda; van Riet, Yvonne E; Siesling, Sabine; Vriens, Birgit E P; Nieuwenhuijzen, Grard A P

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

BMI对HR+/HER2-晚期乳腺癌患者预后的影响:一项基于SONABRE注册研究的分析

Lammers, Senna W M; Thurisch, Hannah; Vriens, Ingeborg J H; Meegdes, Marissa; Engelen, Sanne M E; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Peters, Natascha A J B; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Teeuwen, Nathalie J A; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

SONABRE注册研究分析了新诊断为HER2阳性转移性乳腺癌患者的真实世界治疗模式和生存期的时间趋势。

Geurts, Sandra M E; Ibragimova, Khava I E; Ding, Nan; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; van de Wouw, Agnes J; Maaskant, Sabrina A J G; Teeuwen-Dedroog, Nathalie J A; van Nijnatten, Thiemo J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

HER2阳性晚期乳腺癌患者前四线治疗的疗效:来自SONABRE注册研究的结果

Ibragimova, Khava I E; Geurts, Sandra M E; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; Teeuwen-Dedroog, Nathalie J A; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G

Changes in intestinal microbiota in postmenopausal oestrogen receptor-positive breast cancer patients treated with (neo)adjuvant chemotherapy

接受(新)辅助化疗的绝经后雌激素受体阳性乳腺癌患者肠道菌群的变化

Aarnoutse, Romy; Ziemons, Janine; Hillege, Lars E; de Vos-Geelen, Judith; de Boer, Maaike; Bisschop, Saskia M P; Vriens, Birgit E P J; Vincent, Jeroen; van de Wouw, Agnes J; Le, Giang N; Venema, Koen; Rensen, Sander S; Penders, John; Smidt, Marjolein L

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry

CDK 4/6抑制剂的应用及其对HR+/HER2-晚期乳腺癌患者治疗选择的影响:一项来自荷兰SONABRE注册研究

Meegdes, Marissa; Geurts, Sandra M E; Erdkamp, Frans L G; Dercksen, Marcus Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Teeuwen, Nathalie J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer: a study of the SONABRE registry

初始激素受体/HER2亚型是晚期乳腺癌亚型不一致的主要决定因素:一项基于SONABRE登记研究的调查。

Meegdes, Marissa; Ibragimova, Khava I E; Lobbezoo, Dorien J A; Vriens, Ingeborg J H; Kooreman, Loes F S; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Peters, Natascha A J B; Hochstenbach-Waelen, Ananda; Smidt, Marjolein L; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G

Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls

绝经后乳腺癌患者和对照组的肠道菌群

Aarnoutse, Romy; Hillege, Lars E; Ziemons, Janine; De Vos-Geelen, Judith; de Boer, Maaike; Aerts, Elvira M E R; Vriens, Birgit E P J; van Riet, Yvonne; Vincent, Jeroen; van de Wouw, Agnes J; Le, Giang N; Venema, Koen; Rensen, Sander S; Penders, John; Smidt, Marjolein L